QuickView for transmembrane receptor protein tyrosine phosphatase activity (biogroup)

1. L1000 CMAP - Kidney epithelial HA1E.311 cells with CRISPR targeted gene knockouts
2. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)

There were no matches for transmembrane receptor protein tyrosine phosphatase activity

1. Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Es…
2. Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
3. Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)
4. Pembrolizumab (MK-3475) in MM Patients With Residual Disease
5. Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients